Total Cash From Operating Activities is evolving in a losing momentum direction across reporting periods. The regression slope computed for Tilray Total Cash From Operating Activities from 2010 to 2026 measured a r-value of -0.63 . and standard deviation of 52,114,795 . View All Fundamentals
Use this view alongside Tilray Technical models for added context. It supports structured context for performance and capital structure. Use Tilray Correlation to compare Tilray against competitors. This provides competitive positioning context.
Evaluating Tilray's Total Cash From Operating Activities across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Tilray Inc's fundamental strength.
Latest Tilray's Total Cash From Operating Activities Growth Pattern
Below is the plot of the Total Cash From Operating Activities of Tilray Inc over the last few years. It is Tilray's Total Cash From Operating Activities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tilray's overall financial position and show how it may be relating to other accounts over time.
Tilray Total Cash From Operating Activities Regression Statistics
Arithmetic Mean
-38,168,229
Coefficient Of Variation
-136.54
Mean Deviation
41,523,507
Median
-4,380,870
Standard Deviation
52,114,795
Sample Variance
2716T
Range
185.2M
R-Value
-0.63
Mean Square Error
1763.5T
R-Squared
0.39
Significance
0.01
Slope
-6,455,421
Total Sum of Squares
43455.2T
Tilray Total Cash From Operating Activities History
2026
-80.9 M
2025
-85.1 M
2024
-94.6 M
2023
-30.9 M
2022
7.9 M
2021
-177.3 M
2020
-44.7 M
Stock Overview, Methodology & Data Sources
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. TILRAY INC is traded on Toronto Stock Exchange in Canada. This stock section frames Tilray within its peer set and highlights how fundamentals align with price behavior. Current metrics include P/E of 8.23, P/B of 0.51, profit margin of -2.52%. Tilray has a market cap of 1.1 B, P/E of 8.23, ROE of -84.14%.
Methodology
Unless otherwise specified, financial data for Tilray Inc is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Tilray (CA:TLRY) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We reference public filings and market reference sources and regulatory disclosures, including those published by U.S. Securities and Exchange Commission (SEC) via EDGAR. Data may be normalized and delayed in some cases. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Tilray Inc may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
A comprehensive view of Tilray Inc starts with financial statements and ratio context. Key ratios help frame profitability, efficiency, and growth context for Tilray Inc Stock. Outlined below are key reports that provide context for Tilray Inc Stock:
Use Tilray Correlation to compare Tilray against competitors. This provides competitive positioning context.
With Tilray showing P/E 8.23 and ROE -84.14%, investors get more value when this analysis is combined with the diversification and construction tools below. Those return and profitability levels shape the investment picture - the supplemental tools help investors decide if they are sustainable. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Note that Tilray's intrinsic value and market price are different measures derived from different inputs. For Tilray, key inputs include a P/E ratio of 8.23, a P/B ratio of 0.51, a profit margin of -2.52%, and ROE of -84.14%. In practice, Tilray price is set by the continuous auction process on its listing exchange.